Sami Corwin
Stock Analyst at William Blair
(4.87)
# 333
Out of 4,509 analysts
409
Total ratings
61.3%
Success rate
23.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NGNE Neurogene | Maintained: Buy | n/a | $38.32 | - | 24 | Jun 29, 2026 | |
| ZVRA Zevra Therapeutics | Maintained: Buy | n/a | $13.18 | - | 16 | Jun 24, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $32.67 | - | 10 | Jun 10, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintained: Buy | n/a | $50.63 | - | 19 | Jun 4, 2026 | |
| CABA Cabaletta Bio | Maintained: Buy | n/a | $2.77 | - | 27 | Jun 3, 2026 | |
| KYTX Kyverna Therapeutics | Maintained: Buy | n/a | $7.77 | - | 11 | Jun 3, 2026 | |
| KRYS Krystal Biotech | Maintained: Buy | n/a | $363.44 | - | 18 | May 18, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | n/a | $1.93 | - | 25 | May 14, 2026 | |
| SLDB Solid Biosciences | Maintained: Buy | n/a | $9.72 | - | 19 | May 13, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $24 → $32 | $31.00 | +3.23% | 29 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $25.58 | -26.69% | 1 | May 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.82 | - | 20 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.72 | - | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $59.20 | - | 13 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $81.33 | - | 41 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $33.22 | - | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $41.10 | - | 29 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.8365 | - | 15 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $25.75 | - | 18 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.79 | - | 15 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.20 | - | 15 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.22 | n/a | 5 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.38 | n/a | 4 | Feb 1, 2023 |
Neurogene
Jun 29, 2026
Maintained: Buy
Price Target: n/a
Current: $38.32
Upside: -
Zevra Therapeutics
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $13.18
Upside: -
Tyra Biosciences
Jun 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $32.67
Upside: -
CRISPR Therapeutics AG
Jun 4, 2026
Maintained: Buy
Price Target: n/a
Current: $50.63
Upside: -
Cabaletta Bio
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $2.77
Upside: -
Kyverna Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $7.77
Upside: -
Krystal Biotech
May 18, 2026
Maintained: Buy
Price Target: n/a
Current: $363.44
Upside: -
Allogene Therapeutics
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $1.93
Upside: -
Solid Biosciences
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $9.72
Upside: -
Beam Therapeutics
May 7, 2026
Reiterated: Buy
Price Target: $24 → $32
Current: $31.00
Upside: +3.23%
May 2, 2026
Initiated Coverage: Buy
Price Target: $19
Current: $25.58
Upside: -26.69%
Feb 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $18.82
Upside: -
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $3.72
Upside: -
Feb 24, 2026
Maintained: Hold
Price Target: n/a
Current: $59.20
Upside: -
Feb 20, 2026
Maintained: Buy
Price Target: n/a
Current: $81.33
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: n/a
Current: $33.22
Upside: -
Feb 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $41.10
Upside: -
Jan 9, 2026
Maintained: Buy
Price Target: n/a
Current: $0.8365
Upside: -
Nov 12, 2025
Maintained: Hold
Price Target: n/a
Current: $25.75
Upside: -
Nov 11, 2025
Maintained: Hold
Price Target: n/a
Current: $2.79
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $2.20
Upside: -
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $16.22
Upside: n/a
Feb 1, 2023
Maintained: Buy
Price Target: n/a
Current: $5.38
Upside: n/a